Gemcitabine and Liposomal Doxorubicin (GemDox) for the Treatment of Relapsed and Refractory T-Cell Lymphomas

被引：0
|
作者：
Braunstein, Zachary [1 ]
Waller, Allyson [2 ]
Dotson, Emily [3 ]
McLaughlin, Eric [4 ]
Hanel, Walter [5 ]
Reneau, John C. [5 ]
Addison, Daniel [6 ]
Porcu, Pierluigi [7 ]
Brammer, Jonathan E. [5 ]
机构：
[1] Ohio State Univ, James Canc Hosp, Wexner Med Ctr, Columbus, OH USA
[2] Ohio State Univ, Ctr Comprehens Canc, Dept Pharm, Columbus, OH USA
[3] Ohio State Univ, Wexner Med Ctr, Columbus, OH USA
[4] Ohio State Univ, Ctr Biostat, Columbus, OH USA
[5] Ohio State Univ, Wexner Med Ctr, James Canc Ctr, Columbus, OH USA
[6] Ohio State Univ, Dept Cardiol, Wexner Med Ctr, Columbus, OH USA
[7] Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-184583
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients
    Broccoli, Alessandro
    Stanzani, Marta
    Bandini, Giuseppe
    Bonifazi, Francesca
    Stefoni, Vittorio
    Pellegrini, Cinzia
    LEUKEMIA & LYMPHOMA, 2013, 54 (08) : 1791 - 1793
  • [42] Ifosfamide and etoposide in advanced-stage, relapsed or refractory primary cutaneous T-cell lymphomas
    Dangien, A.
    Ram-Wolff, C.
    Brice, P.
    Battistella, M.
    Roelens, M.
    Moins-Teisserenc, H.
    Peffault de Latour, R.
    Mourah, S.
    Bouaziz, J. -D.
    Lebbe, C.
    Bagot, M.
    de Masson, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (05) : 961 - 962
  • [43] Liposomal tretinoin: Promising early results of an ongoing phase II trial in relapsed or refractory non-Hodgkin's lymphomas (NHL) and cutaneous T-cell lymphomas (CTCL).
    Sarris, AH
    Hagemeister, F
    McLaughlin, P
    Rodriguez, MA
    Pro, B
    Romaguera, J
    Zipf, T
    Mesina, O
    Medeiros, LJ
    Oholendt, M
    Lopez-Berenstein, G
    Ford, R
    Williams, T
    Cabanillas, F
    BLOOD, 2000, 96 (11) : 136A - 136A
  • [44] Phase I study of gemcitabine and liposomal doxorubicin in relapsed ovarian cancer
    D'Agostino, G
    Ferrandina, G
    Garganese, G
    Salerno, MG
    Lorusso, D
    Farnetano, MG
    Mancuso, S
    Scambia, G
    ONCOLOGY, 2002, 62 (02) : 110 - 114
  • [45] Pegylated Liposomal Doxorubicin A Review of its Use in the Treatment of Relapsed or Refractory Multiple Myeloma
    Plosker, Greg L.
    DRUGS, 2008, 68 (17) : 2535 - 2551
  • [46] Pharmacodynamic and pharmacokinetic study of pegylated liposomal doxorubicin combination (CCOP) chemotherapy in patients with peripheral T-cell lymphomas
    Fan, Yun
    Lin, Neng-Ming
    Luo, Lue-hong
    Fang, Luo
    Huang, Zhi-yu
    Yu, Hai-feng
    Wu, Feng-qin
    ACTA PHARMACOLOGICA SINICA, 2011, 32 (03) : 408 - 414
  • [47] Salvage chemotherapy of gemcitabine, dexamethasone, and cisplatin (GDP) for patients with relapsed or refractory peripheral T-cell lymphomas: a consortium for improving survival of lymphoma (CISL) trial
    Park, Byeong-Bae
    Kim, Won Seog
    Suh, Cheolwon
    Shin, Dong-Yeop
    Kim, Jeong-A
    Kim, Hoon-Gu
    Lee, Won Sik
    ANNALS OF HEMATOLOGY, 2015, 94 (11) : 1845 - 1851
  • [48] Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation Study
    Vu, Khoan
    Wu, Chi-Heng
    Yang, Chen-Yen
    Zhan, Aaron
    Cavallone, Erika
    Berry, Wade
    Heeter, Pamela
    Pincus, Laura
    Wieduwilt, Matthew J.
    William, Basem M.
    Andreadis, Charalambos
    Kaplan, Lawrence K.
    McCormick, Frank
    Porcu, Pierluigi
    Brammer, Jonathan E.
    Ai, Weiyun Z.
    CLINICAL CANCER RESEARCH, 2020, 26 (05) : 1000 - 1008
  • [49] A Phase 1 Trial of Alisertib and Romidepsin for Relapsed/Refractory Aggressive B-Cell and T-Cell Lymphomas
    Strati, Paolo
    Oki, Yasuhiro
    Fayad, Luis E.
    Nastoupil, Loretta
    Fowler, Nathan H.
    Hagemeister, F. B.
    Kwak, Larry W.
    Lee, Hun Ju
    Wang, Michael
    Westin, Jason R.
    Ruben, Charnelle
    Wesson, Emily
    Fanale, Michelle A.
    BLOOD, 2017, 130
  • [50] Pharmacodynamic and pharmacokinetic study of pegylated liposomal doxorubicin combination (CCOP) chemotherapy in patients with peripheral T-cell lymphomas
    Yun Fan
    Neng-ming Lin
    Lü-hong Luo
    Luo Fang
    Zhi-yu Huang
    Hai-feng Yu
    Feng-qin Wu
    Acta Pharmacologica Sinica, 2011, 32 : 408 - 414
12345